N-acetylcysteine treatment following spinal cord trauma reduces neural tissue damage and improves locomotor function in mice

Mol Med Rep. 2015 Jul;12(1):37-44. doi: 10.3892/mmr.2015.3390. Epub 2015 Feb 26.

Abstract

Following spinal cord trauma, mitochondrial dysfunction associated with increased oxidative stress is a critical event leading to leukocyte inflammatory responses, neuronal cell death and demyelination, contributing to permanent locomotor and neurological disability. The present study demonstrated that the mitochondrial enhancer N-acetylcysteine (NAC) may restore redox balance via enhancement of mitochondrial respiratory activity following traumatic spinal cord injury (SCI). In addition, NAC ameliorates oxidative stress-induced neuronal loss, demyelination, leukocyte infiltration and inflammatory mediator expression and improves long-term locomotor function. Furthermore, neuronal survival and neurological recovery are significantly correlated with increased mitochondrial bioenergetics in SCI following treatment with NAC. Therefore, NAC may represent a potential therapeutic agent for preserving mitochondrial dynamics and integrity following traumatic SCI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / administration & dosage*
  • Animals
  • Disease Models, Animal
  • Humans
  • Mice
  • Motor Activity / drug effects*
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuroprotective Agents / administration & dosage*
  • Oxidation-Reduction
  • Oxidative Stress / drug effects
  • Recovery of Function / drug effects
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / metabolism
  • Spinal Cord Injuries / physiopathology

Substances

  • Neuroprotective Agents
  • Acetylcysteine